Internal Medicine, Hematology & Oncology · Greensboro, NC
NPI
1851374292
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
501 N Elam Ave
Greensboro, NC, 27403
Phone (336) 832-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
776 services
Medicare patients, 2024
393
Average age 74
Drug cost, 2024
$3.1M
3,905 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vinay K Gudena was code 99214 (office e&m - established), 312 times for 109 patients. In total Vinay K Gudena billed 776 services in 13 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 312 | 109 | $66.85 | $21K |
| 99213 Office E&M - Established | Facility | 285 | 249 | $42.22 | $12K |
| 99442 Telephone Services | Facility | 74 | 53 | $42.77 | $3,165 |
| 99205 Office E&M - New | Facility | 42 | 42 | $106.04 | $4,454 |
| 99211 Office E&M - Established | Facility | 24 | 23 | $5.72 | $137 |
| 99215 Office E&M - Established | Facility | 12 | 12 | $98.13 | $1,178 |
By year: 2022 $40K for 662 services; 2023 $46K for 797 services; 2024 $43K for 776 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vinay K Gudena prescribed most often to Medicare patients was Anastrozole, with 1,166 prescriptions and refills. In total Vinay K Gudena wrote 3,905 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 1,166 | 3,278 | 351 | $29K |
| Letrozole Generic | 692 | 1,909 | 205 | $20K |
| Tamoxifen Citrate Generic | 503 | 1,382 | 150 | $14K |
| Gabapentin Generic | 97 | 180 | 30 | $1,784 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 90 | 225 | 23 | $1,811 |
| Ibrance Palbociclib | 89 | 90 | Under 11 | $1.3M |
| Ondansetron Hcl Generic | 78 | 83 | 57 | $679 |
| Alendronate Sodium Generic | 69 | 193 | 22 | $927 |
| Prochlorperazine Maleate Generic | 66 | 66 | 45 | $761 |
| Xarelto Rivaroxaban | 58 | 92 | 17 | $50K |
| Verzenio Abemaciclib | 58 | 58 | 14 | $889K |
| Alprazolam Generic | 56 | 57 | 13 | $154 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 54 | 57 | 39 | $754 |
| Hydroxyurea Generic | 44 | 72 | Under 11 | $912 |
| Lorazepam Generic | 40 | 40 | 17 | $98.94 |
Brand drugs: 344 claims; generic drugs: 3,561 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vinay K Gudena $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.